Skylight Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.10 M
- Revenue Growth -0.58%
- Profit Growth -74.82%
- Ebitda 11.57%
- Net Worth 5.60%
- Total Assets 16.44%
About Skylight Pharmaceuticals
Skylight Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 2016 (Eight years and nine months 1 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.10 M.
Sharma Amit and Falak Sharma serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC280526
-
Company No.
280526
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 May 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Skylight Pharmaceuticals Private Limited offer?
Skylight Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Pharmaceutical Tablets.
Who are the key members and board of directors at Skylight Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharma Amit
|
Director | 30-Sep-2024 | Current |
|
Falak Sharma
|
Director | 30-Sep-2022 | Current |
Financial Performance of Skylight Pharmaceuticals.
Skylight Pharmaceuticals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.58% decrease. The company also saw a substantial fall in profitability, with a 74.82% decrease in profit. The company's net worth moved up by a moderate rise of 5.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skylight Pharmaceuticals?
In 2021, Skylight Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Winmax Logistics Private LimitedSharma Amit is a mutual person
Charges (Loans)
₹4.10 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2019 | State Bank Of India | ₹4.10 M | Open |
How Many Employees Work at Skylight Pharmaceuticals?
Unlock and access historical data on people associated with Skylight Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skylight Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylight Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
